drugset / Trial / NCT02474186
Phase II Study for Solid Metastatic Tumors
NaSingle-groupOpen-labelTreatment
Summary
1. To induce immunity-mediated tumor response outside the radiation field (abscopal effect) after chemo-radiation of a metastatic site in metastatic breast cancer patients. 2. To monitor the induction of a T cell response. 3. To explore the role of PET scanning to assess tumor responses/abscopal effect.
Timeline
- Start
- 2003-04
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Capecitabine | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | — | — |